BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32743497)

  • 1. Potentially inappropriate anticholinergic drug prescriptions for patients with Sjögren's syndrome.
    Valladales-Restrepo LF; Machado-Alba JE
    J Transl Autoimmun; 2019 Dec; 2():100007. PubMed ID: 32743497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially Inappropriate Prescriptions for Anticholinergic Medications for Patients with Constipation.
    Valladales-Restrepo LF; Paredes-Mendoza M; Machado-Alba JE
    Dig Dis; 2020; 38(6):500-506. PubMed ID: 32135532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia.
    Valladales-Restrepo LF; Machado-Alba JE
    Aging Male; 2020 Dec; 23(5):785-792. PubMed ID: 30955405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma.
    Valladales-Restrepo LF; Machado-Alba JE
    Int Ophthalmol; 2020 Apr; 40(4):803-809. PubMed ID: 31792854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
    Valladales-Restrepo LF; Duran-Lengua M; Machado-Alba JE
    Geriatr Gerontol Int; 2019 Sep; 19(9):913-917. PubMed ID: 31342625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic Risk and Frequency of Anticholinergic Drug Prescriptions in a Population Older Than 65.
    Machado-Alba JE; Castro-Rodríguez A; Álzate-Piedrahita JA; Hoyos-Pulgarín JA; Medina-Morales DA
    J Am Med Dir Assoc; 2016 Mar; 17(3):275.e1-4. PubMed ID: 26791416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.
    Generali E; Costanzo A; Mainetti C; Selmi C
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):357-370. PubMed ID: 28871434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of Sjögren's syndrome patients with pilocarpine-tablets.
    Vivino FB
    Scand J Rheumatol Suppl; 2001; 115():1-9; discussion 9-13. PubMed ID: 11469515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective.
    Cartee DL; Maker S; Dalonges D; Manski MC
    J Dent Hyg; 2015 Dec; 89(6):365-71. PubMed ID: 26684993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stomatological approach to Sjögren's syndrome: diagnosis, management and therapeutical timing.
    Minozzi F; Galli M; Gallottini L; Minozzi M; Unfer V
    Eur Rev Med Pharmacol Sci; 2009; 13(3):201-16. PubMed ID: 19673172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren's syndrome.
    Gresz V; Horvath A; Gera I; Nielsen S; Zelles T
    Oral Dis; 2015 Jan; 21(1):e114-20. PubMed ID: 24661359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study.
    Papas AS; Sherrer YS; Charney M; Golden HE; Medsger TA; Walsh BT; Trivedi M; Goldlust B; Gallagher SC
    J Clin Rheumatol; 2004 Aug; 10(4):169-77. PubMed ID: 17043506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis on pharmacological therapies in the management of xerostomia in patients with Sjogren's syndrome.
    Garlapati K; Kammari A; Badam RK; B E S; Boringi M; Soni P
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):312-318. PubMed ID: 30932714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
    Riega-Torres JC; Villarreal-Gonzalez AJ; Ceceñas-Falcon LÁ; Salas-Alanis JC
    Gac Med Mex; 2016; 152(3):371-80. PubMed ID: 27335194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: a population based study in a French region.
    Beuscart JB; Dupont C; Defebvre MM; Puisieux F
    Arch Gerontol Geriatr; 2014; 59(3):630-5. PubMed ID: 25192614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic floor dysfunction in female Sjögren's syndrome: an 8-year audit.
    Budden AK; Te West NI; Sturgess AD; Moore KH
    Int Urogynecol J; 2016 Sep; 27(9):1367-73. PubMed ID: 26965411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.